Endovia Health Sciences, Inc.
EDVA- Exchange
- NYSE
- Industry
- Beverages
- SEC CIK
- 0001553788
No open-market purchases or sales by Endovia Health Sciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $172.1K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Endovia Health Sciences, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +2 vs. Q1 2026
- Shares held
- 1.11M
- +430.7K (+63.4%) vs. Q1 2026
- Total value
- $172.1K
- −$71.9K (−29.5%) vs. Q1 2026
- New holders
- 6
- 3 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EDVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $172.1K |
| Q1 2026 | 16 | $243.9K |
| Q4 2025 | 14 | $150.7K |
| Q3 2025 | 17 | $255.7K |
| Q2 2025 | 12 | $260.9K |
| Q1 2025 | 11 | $93.4K |
| Q4 2024 | 34 | $720.8K |
| Q3 2024 | 31 | $1.04M |
| Q2 2024 | 32 | $903.3K |
| Q1 2024 | 28 | $1.37M |
| Q4 2023 | 30 | $1.40M |
| Q3 2023 | 28 | $1.61M |
| Q2 2023 | 26 | $2.93M |
| Q1 2023 | 21 | $3.45M |
| Q4 2022 | 24 | $2.19M |
| Q3 2022 | 23 | $2.83M |
| Q2 2022 | 22 | $6.81M |
| Q1 2022 | 25 | $7.96M |
| Q4 2021 | 15 | $484.0K |
| Q3 2021 | 13 | $919.0K |
| Q2 2021 | 9 | $1.01M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Endovia Health Sciences, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 5 | $1 | 0.00% | −68−93.2% | Reduced |
| Delos Wealth Advisors, LLC | 16 | $3 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 470 | $73 | 0.00% | +470 | New |
| Tower Research Capital LLC (TRC) | 4,019 | $623 | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 10,934 | $1.70K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 20,405 | $3.16K | 0.00% | +20,405 | New |
| RSM US Wealth Management LLC | 34,027 | $5.27K | 0.00% | 00.0% | Unchanged |
| StoneX Group Inc. | 28,151 | $5.35K | 0.00% | +28,151 | New |
| HRT Financial LP | 56,687 | $8.00K | 0.00% | −77,769−57.8% | Reduced |
| Point72 Asset Management, L.P. | 56,950 | $8.83K | 0.00% | +56,950 | New |
| Virtu Financial LLC | 59,897 | $9.00K | 0.00% | −40,288−40.2% | Reduced |
| Compass Financial Management LLC | 64,500 | $10.0K | 0.00% | +64,500 | New |
| Lifetime Wealth Management P.C. | 66,050 | $10.2K | 0.01% | 00.0% | Unchanged |
| Truist Financial Corp | 67,819 | $10.5K | 0.00% | +35,000+106.6% | Added |
| Geode Capital Management, LLC | 68,591 | $10.6K | 0.00% | +11,154+19.4% | Added |
| Summit Trail Advisors, LLC | 100,000 | $15.5K | 0.00% | 00.0% | Unchanged |
| Phraction Management LLC | 123,648 | $19.2K | 0.00% | +53,648+76.6% | Added |
| Jane Street Group, LLC | 348,418 | $54.0K | 0.00% | +348,418 | New |
| UBS Group AG | 0 | $0 | 0.00% | −53,111−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,585−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |